Utilizing a combination of patient brain tissue and genome editing of a mouse model, they demonstrated that in glioblastoma, IDH-wildtype driver mutations seen in the main tumor matched those seen in corresponding SVZ tissue. This evidence concerns the gene IDH2 and neoplasm.